Información de Integra Lifesciences Holdings Corp, dividendo de Integra Lifesciences Holdings Corp, actividades de los accionistas y más

Más Datos de Integra Lifesciences Holdings Corp Compañía

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Información de Integra Lifesciences Holdings Corp



Símbolo de cotizaciónIART

Nombre de la empresaIntegra Lifesciences Holdings Corp

Fecha de salida a bolsaAug 16, 1995

Director ejecutivoPoul (Mojdeh)

Número de empleados4396

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 16

Dirección1100 Campus Road

CiudadPRINCETON

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal08540

Teléfono16092750500

Sitio Webhttps://www.integralife.com/

Símbolo de cotizaciónIART

Fecha de salida a bolsaAug 16, 1995

Director ejecutivoPoul (Mojdeh)

Ejecutivos de Integra Lifesciences Holdings Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+26531.00%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+19200.00%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-2561.00%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-4282.00%

Mr. Harvinder Singh

Executive Vice President, President - International Business

21.94K

+8684.00%

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

--

Mr. Robert T. Davis, Jr.

Executive Vice President, President - Tissue Technologies

--

Ms. Barbara B. Hill

Independent Presiding Director

--

Mr. Eric I. Schwartz

Executive Vice President, Chief Legal Officer, Secretary

--

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+26531.00%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+19200.00%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-2561.00%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-4282.00%

Mr. Harvinder Singh

Executive Vice President, President - International Business

21.94K

+8684.00%

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Neurosurgery

201.56M

50.13%

Wound Reconstruction and Care

83.99M

20.89%

Instruments

50.15M

12.47%

ENT

40.87M

10.16%

Private Label

25.49M

6.34%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

295.85M

73.58%

Europe

42.89M

10.67%

Asia Pacific

42.68M

10.62%

Rest of World

20.64M

5.13%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Neurosurgery

201.56M

50.13%

Wound Reconstruction and Care

83.99M

20.89%

Instruments

50.15M

12.47%

ENT

40.87M

10.16%

Private Label

25.49M

6.34%

Estadísticas de accionistas

Actualizado: sáb., 15 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.92%

TRU ST Partnership, L.P.

10.93%

Rubric Capital Management LP

9.83%

The Vanguard Group, Inc.

9.13%

Fuller & Thaler Asset Management Inc.

5.03%

Otro

53.16%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.92%

TRU ST Partnership, L.P.

10.93%

Rubric Capital Management LP

9.83%

The Vanguard Group, Inc.

9.13%

Fuller & Thaler Asset Management Inc.

5.03%

Otro

53.16%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

36.64%

Investment Advisor/Hedge Fund

36.54%

Hedge Fund

18.48%

Corporation

10.93%

Individual Investor

3.20%

Research Firm

2.31%

Pension Fund

1.48%

Bank and Trust

0.40%

Sovereign Wealth Fund

0.04%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

584

74.73M

95.94%

-24.99M

2025Q3

583

73.55M

94.42%

-25.07M

2025Q2

600

89.38M

114.72%

-18.72M

2025Q1

635

87.01M

111.97%

-18.30M

2024Q4

636

81.93M

106.10%

-20.27M

2024Q3

638

82.93M

106.93%

-12.58M

2024Q2

628

84.82M

107.92%

-1.75M

2024Q1

613

79.36M

101.18%

-3.69M

2023Q4

597

79.81M

101.26%

-5.74M

2023Q3

592

81.88M

100.31%

-3.94M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

9.29M

11.92%

-146.58K

-1.55%

Sep 30, 2025

TRU ST Partnership, L.P.

8.52M

10.93%

--

Feb 28, 2025

Rubric Capital Management LP

7.65M

9.83%

+300.00K

+4.08%

Sep 30, 2025

The Vanguard Group, Inc.

7.29M

9.36%

-217.24K

-2.89%

Sep 30, 2025

Fuller & Thaler Asset Management Inc.

3.91M

5.03%

+21.91K

+0.56%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

3.18M

4.09%

+267.13K

+9.16%

Sep 30, 2025

Invesco Advisers, Inc.

3.18M

4.09%

+3.31K

+0.10%

Sep 30, 2025

State Street Investment Management (US)

2.79M

3.58%

-35.57K

-1.26%

Sep 30, 2025

Boston Management and Research

2.74M

3.52%

--

Sep 30, 2025

Paradigm Capital Management, Inc.

2.53M

3.25%

+348.30K

+15.97%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

iShares Neuroscience and Healthcare ETF

1.44%

State Street SPDR S&P Health Care Equipment ETF

1.39%

ROBO Global Healthcare Technology & Innovation ETF

1.02%

Invesco S&P SmallCap Health Care ETF

0.49%

Invesco NASDAQ Future Gen 200 ETF

0.43%

Inspire Small/Mid Cap ESG ETF

0.19%

Royce Quant Small-Cap Quality Value ETF

0.13%

Principal U.S. Small-Cap ETF

0.13%

iShares S&P Small-Cap 600 Value ETF

0.12%

State Street SPDR S&P 600 Small Cap Value ETF

0.11%

iShares Neuroscience and Healthcare ETF

Proporción1.44%

State Street SPDR S&P Health Care Equipment ETF

Proporción1.39%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.02%

Invesco S&P SmallCap Health Care ETF

Proporción0.49%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.43%

Inspire Small/Mid Cap ESG ETF

Proporción0.19%

Royce Quant Small-Cap Quality Value ETF

Proporción0.13%

Principal U.S. Small-Cap ETF

Proporción0.13%

iShares S&P Small-Cap 600 Value ETF

Proporción0.12%

State Street SPDR S&P 600 Small Cap Value ETF

Proporción0.11%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos